DEA Temporarily Schedules Synthetic Kratom Compound
The Drug Enforcement Administration (DEA) recently announced that it will temporarily schedule a synthetic version of kratom known as 7-hydroxymitragynine (7-OH), in […]
SAM Recognizes National Marijuana Facts Week
Given that July 4–10 is National Marijuana Facts Week, the Drug Report has compiled a list of facts from the 2024 National Survey on Drug Use
Day 6, Part II: Father Who Lost His Son to a Drugged Driver Warns Rescheduling Will Put More Impaired Drivers on the Road
The federal marijuana rescheduling hearing turned Tuesday to a danger the government’s own proposal barely mentions: drugged driving. DUID Victim Voices opened
Day Six: SAM Turns the Government’s Own DEA Scientist Into Its Best Witness Against Rescheduling
Smart Approaches to Marijuana concluded its case-in-chief in the federal rescheduling hearing Tuesday by calling one of the DEA’s own pharmacologists and
Day Five: SAM Opens Its Case and Puts a Harvard Scientist the Government Once Relied On Against Rescheduling
Smart Approaches to Marijuana opened its case in the federal rescheduling hearing Monday with a simple argument: nothing about the science has
Thursday Fact: 84% of past-year marijuana users did not report using marijuana that was recommended by a doctor
Thursday Edition of Friday Fact due to the July 4th Holiday: Federal data indicate that the vast majority of marijuana users use it exclusively as
Day Four: NDASA Makes Its Case Efficiently and Effectively
The National Drug and Alcohol Screening Association presented a focused, credible case-in-chief on behalf of the drug and alcohol testing
Day Three: The Government’s Pain Expert Struggles Under Cross-Examination
Day three of the federal marijuana rescheduling hearing was dominated by the continued cross-examination of Dr. Cory Burchman, the retired
Non-Fatal Overdoses Have Risen Since 2021
United Against Fentanyl, a DC-based drug policy organization, recently asserted that “in 2026, overdoses in the United States are at
Study Finds that Marijuana Commercialization Drives Marijuana Use and Related Harms
A recent study in Lancet Psychiatry, which reviewed global data from 2000–2025, found that the commercialization of marijuana in the